About
Daniel M. Skovronsky is based out of Indianapolis, Indiana and is the Chief Scientific and Product Officer and President of Eli Lilly. Daniel previously worked at Avid Radiopharmaceuticals as a Founder. Daniel M. Skovronsky attended the University of Pennsylvania and Yale University. Daniel M. Skovronsky has been received the honor in Time Magazine 100 Most Influential people in health, Honorary Doctorate of Medicine from Oakland University, and the Melvin R. Goodes Prize by the Alzheimer’s Drug Discovery Foundation in their career. Daniel M. Skovronsky has been named as the 2025 Kavli Oxford Lecture Award recipient by the University of Oxford (United Kingdom), Cleveland Clinic #1 Innovation of 2011 (for amyloid imaging), the 2021 Roy VagelosPro Bono Humanum Award (for COVID19 antibody), and the Galien Foundation 2023 Best Pharmaceutical Product Prix Galien (for tirzepatide) in their career.
Position in the VCSift Database
- • 2 investors at Eli Lilly are tracked.
- • 1 investors hold the Chief Scientific and Product Officer and President role in VCSift. Daniel Skovronsky is one of them.
- • 258 investors are based in Indianapolis, Indiana, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Indianapolis, US
Contact Information
Find more investors like Daniel
Search Investors